BioForce announces new sale to Harvard Medical School

Nov. 13, 2006 — Hot on the heels of a sale to the University of Rochester Medical Center, BioForce Nanosciences Inc. of Ames, Iowa, announced the completion of a Nano eNabler system sale to the Technology & Engineering Center at Harvard Medical School. Funding for the purchase was provided by an award from the National Human Genome Research Institute.

Dale Larson, director of the center, is leading the use of the Nano eNabler system. His group is utilizing the system to print very small femtoliter volumes of biomolecules onto specially developed nanohole array sensors with sub-micron dimensions.

The technology is being developed for use in drug discovery and development, biomarker screening, diagnostic assays, and homeland security applications. The nanohole array sensing technology is a label-free detection system that is very sensitive and highly multiplexed. The Nano eNabler system enables the printing of many different capture agents on their chip, allowing researchers to simultaneously study many different binding interactions from one sample on one chip.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.